Millie
your market intelligence analyst
Search Results
Edit Save
188,960 results
The selections or defaults defined for this collection may have been too restrictive for this search query. You can refine your results for this search.
Novinky (Czech Republic) 11/19/2019 07:38
Německá policie zadržela v pátek poblíž hranic s ČR několik migrantů, kteří údajně přijeli v nákladním autě, poblíž hraničního přechodu v Lískové na Domažlicku vystoupili a s převaděči přešli pěšky do Německa. Tamní policisté se obracejí na českou veřejnost a hledají svědky, kteří v pátek kolem 6:00 viděli vystupovat u hraničního přechodu větší počet lidí z nákladního auta nebo si všimli něčeho podezřelého.
RosBusiness (Russian) 11/19/2019 07:37
В НАТО приветствуют решение России передать задержанные в Керченском проливе корабли Украине, заявил генеральный секретарь НАТО Йенс Столтенберг в ходе пресс-конференции в Брюсселе. Видео его ...
საქართველოს მთავრობის მეთაურმა ოპოზიციას შეახსენა, რომ საპროტესტო აქციის დროს აკრძალულია პარლამენტის შენობის შესასვლელების ბლოკირება.
Busness Insider 11/19/2019 07:34
Starling's head of banking compliance Rachel Coote has quit to join startup Paybase. Coote is the sixth senior employee to leave the buzzy finance company in 2019. The company's chief financial officer Tony Ellingham has confirmed he will also depart within the next year. Starling downplayed the significance of Cooke's departure in a statement, and said her move was "not a setback.". Word of Coote's departure comes just as Starling announced it had reached one million accounts. Buzzy UK finance startup Starling Bank has lost a sixth high-ranking employee this year, amid a backdrop of executive departures. Rachel Coote, the firm's former head of compliance for banking services, has quit to take on a similar role at Paybase, a flexible payment.
ENDPOINTS 11/19/2019 07:32
Myovant has long had a secret weapon in its gonad rivalry with AbbVie: Men. Lynn Seely Myovant. While the small Swiss biotech has with the Illinois-based giant for a foothold in the endometriosis and uterine fibroid therapy market, the company has been developing the same lead compound, relugolix, for use in one of the most common cancers for the uterus-less: prostate cancer.

Automotive Industries

Business Issues

Companies - Public

Companies - Venture Funded

Global Markets

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Market Research Topics

Political Entities

Sources

Strategic Scenarios

Trends